Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xianhe,Xie

第一单位： a Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University , Fuzhou , China.

作者： Xianhe,Xie ^[1] ; Junjin,Liu ^[1] ; Haitao,Yang ^[1] ; Huijuan,Chen ^[1] ; Sijing,Zhou ^[1] ; Heng,Lin ^[1] ; Ziyuan,Liao ^[1] ; Yin,Ding ^[1] ; Liting,Ling ^[1] ; Xuewen,Wang ^[1]

作者单位： a Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University , Fuzhou , China. ^[1]

关键词 Melanoma immune checkpoint inhibitors (ICI)metastatic renal cell carcinoma (mRCC)neutrophil-to-lymphocyte ratio (NLR)non-small cell lung cancer (NSCLC)

主题词抗肿瘤药(Antineoplastic Agents);女(雌)性(Female);人类(Humans);免疫疗法(Immunotherapy);淋巴细胞计数(Lymphocyte Count);淋巴细胞(Lymphocytes);男(雄)性(Male);中性白细胞(Neutrophils);预后(Prognosis)

DOI 10.1080/07357907.2019.1639057

PMID 31304800

发布时间 2019-08-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Cancer investigation

2019年37卷6期

265-274页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.

Cancer investigation

相似文献

Cancer investigation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.

Cancer investigation

相似文献

Cancer investigation

相关期刊

检索历史清除